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Abstract
Although the life expectancy of people living with HIV/AIDS (PLWH) has increased in the past years, they could experience secondary
illness such as peripheral neuropathy (PN). Therefore, they need to adapt to chronic disablement which could affect their quality of life
(QoL). The research that informed this article aimed at determining the prevalence of PN among adults living with HIV/AIDS and
attending the outpatients’ clinic at Rutongo Hospital in the Rulindo district of Rwanda. Another aim was to determine these
patients’ QoL. A cross-sectional descriptive quantitative research design was used. A time-constrained method was used to sample
185 adults living with HIV/AIDS and attending the outpatients’ clinic at Rutongo Hospital. The subjective PN screen and the
World Health Organization Quality of Life Scale Brief Version were used to collect the data. Data were analysed using the
Statistical Package for the Social Sciences. Student’s t-test and one-way analysis of variance were performed to determine if
signiﬁcant differences existed between QoL scores in participants with and without PN symptoms. The results indicated that 40.5%
of respondents experienced PN. QoL in participants with PN showed signiﬁcantly lower scores in the physical (p ¼ 0.013) and
psychological (p ¼ 0.020) domains when compared with those who did not have PN. These results indicate a high prevalence of
neuropathy among PLWH attending the outpatients’ clinic at Rutongo Hospital. In addition, patients with neuropathy had lower
QoL scores in the physical and psychological domains than those without neuropathy symptoms. The management of PLWH
should therefore include interventions to optimise QoL as well as screening for neuropathy symptoms so that sufferers can liaise
with their medical providers to ﬁnd medical and supportive therapies that could assist them.
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Re´sume´
Bien que l’espe´rance de vie des personnes vivant avec le VIH/ SIDA (PVVIH) a augmente´ ces dernie`res anne´es, ils pourraient subir une
maladie secondaire comme la neuropathie pe´riphe´rique (NP). Par conse´quent, ils ont besoin de s’adapter a` l’invalidite´ chronique qui
pourrait affecter leur qualite´ de vie (QdV). La recherche qui a informe´ cet article vise a` de´terminer la pre´valence de la NP chez les
adultes vivant avec le VIH/SIDA et qui fre´quentent la clinique externe de l’hoˆpital de Rutongo dans le district de Rulingo au Rwanda.
Un autre objectif e´tait de de´terminer la qualite´ de vie de ces patients QdV. Un mode`le d’e´tude transversale quantitative et descriptive a
e´te´ utilise´. Une me´thode de contrainte de temps a e´te´ utilise´e pour e´chantillonner 185 adultes vivant avec le VIH/ SIDA qui fre´quentent
la clinique externe de l’hoˆpital de Rutongo. L’examen subjectif de NP et le WHOQOL BREF ont e´te´ utilise´s pour collecter les donne´es.
Celles-ci ont e´te´ analyse´es en utilisant le logiciel de statistiques des sciences sociales. Le test-t et l’analyse de variance ont e´te´ effectue´s
aﬁn de de´terminer si des diffe´rences signiﬁcatives existent entre les scores de qualite´ de vie Qdv chez les participants avec et sans
symptoˆmes NP. Les re´sultats indiquent que 40,5% des re´pondants ont eu le NP. La qualite´ de vie chez les participants ayant le NP a
montre´ des scores signiﬁcativement plus faibles dans les domaines physique (p ¼ 0.013) et psychologique (p ¼ 0.020) compare´ a` ceux
qui n’ont pas eu de NP. Ces re´sultats indiquent une pre´valence e´leve´e de la neuropathie chez les PVVIH fre´quentant une clinique
externe de l’hoˆpital de Rutongo. En outre, les patients atteints de neuropathie avaient des scores de QdV moins e´leve´ dans les domaines
physique et psychologique que ceux qui n’avaient pas de symptomes de neuropathie. La gestion des PVVIH devraient donc inclure des
interventions aﬁn d’optimiser la qualite´ de vie ainsi que le de´pistage des symptomes de neuropathie de telle sorte que les malades
puissent assurer une liaison avec les fournisseurs de soinsme´dicaux pour trouver des the´rapiesme´dicales de soutien qui pourraient les aider.
Mots cle´s: Neuropathie Pe´riphe´rique VIH/SIDA, Qualite´ de vie, Rwanda, WHOQOL BREF
Introduction
People living with HIV/AIDS (PLWHs) have a higher life expect-
ancy than before. Thus, they are presenting with more chronic
health problems and are not only concerned with a treatment’s
ability to extend life but also with the quality of the life they are
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able to lead (Demmer 2001; Gale 2003). Quality of life (QoL) for
patients living with HIV has become increasingly important, with
the goals of therapy now including improvement of QoL in
addition to the reduction of symptoms, suppression of the virus
and extension of survival (Casado 2005; Globe, Hays & Cunning-
ham 1999). QoL among HIV-infected individuals has been
studied extensively, and prior research has attempted to assess
QoL and determine predictors for good or poor QoL in this
context (Mweemba 2008).
Peripheral neuropathy (PN) is one condition associated with
functional limitations which can affect the QoL of patients.
Chronic painful symptoms as experienced with PN can have a
considerable impact on an individual’s life and may be associated
with anxiety, depression and loss of mobility and independence
(Benbow, Wallmahmed & Mcfarlane 1998; Breitbart & Dibiase
2002; Pandya, Krentz, Gill & Power 2005). Thus, increased and
improved surveillance for HIV-associated PN will allow earlier
interventions to improve QoL and prevent severe toxicities. The
ability to cope with a disease such as HIV/AIDS seems to inﬂu-
ence certain domains of QoL (Jia, Uphold, Wu, Reid, Findley &
Duncan 2004; Vosvick, Koopman, Gore-Felton, Thoresen, Krum-
boltz & Spiegel 2003).
It is therefore important to identify the QoL of PLWH in different
population groups in order to plan and implement effective inter-
vention programmes. Illnesses associated with HIV/AIDS have
been reported to have an impact on the QoL of PLWH. To
date, there has been no published study that has assessed PN
and QoL of PLWH in Rwanda. This information is important
as this country was identiﬁed as one of the sub-Saharan countries
most severely affected by HIV/AIDS (WHO 2005). Furthermore,
the 1995 genocide in Rwanda resulted in the increase of women
being affected by HIV and greater instability of the health-care
system. Although the management of HIV/AIDS in this
country includes the provision of antiretroviral drugs (ARVs)
and psychological support, it was deemed important to determine
whether there are other needs of PLWHs in this country which
could be addressed. Therefore, the aim of this study was to deter-
mine the prevalence of PN among adults living with HIV/AIDS
and the QoL of such people attending the outpatients’ clinic at
Rutongo Hospital in the Rulindo district in Rwanda. Particular
attention was paid to speciﬁc aspects of QoL. This included phys-
ical, psychological, social relationships and environmental
domains.
Methods
A cross-sectional descriptive design was used to collect the data.
Approximately 35 adults living with HIV/AIDS attend Rutongo
Hospital per week to receive medication. The study was con-
ducted over a 6-week period. A time-constrained sample of 185
PLWH attending this hospital was recruited to participate in
the study. The patients attending the outpatients’ clinic included
those who were receiving highly active antiretroviral therapy
(HAART) and those who needed assessment of their CD4
counts but were not receiving medication. Only those patients
attending the outpatients’ clinic who had a conﬁrmed diagnosis
of HIV/AIDS, were over 18 years, able to provide informed
consent and ﬂuent in Kinyarwanda (an indigenous Rwandan
language) or English at the time of data collection were included
in the study. Permission to conduct the study was sought from
relevant committees at the University of the Western Cape as
well as the relevant Rwandan authorities. Written consent was
sought from the participants.
Two validated instruments were used to collect data. The subjec-
tive PN screen (SPNS) was used to screen for the presence of PN
(McArthur 1998). The SPNS asks about three symptoms which
cover the following: ‘pain, aching or burning’; ‘pins and needles’
(paraesthesias) and ‘numbness’. Each of these three different
symptoms was rated either as never occurring or occurring. If
present at the time of data collection, the severity of the symptoms
was scored on a scale from 1 (mild) to 10 (most severe). The sub-
jective neuropathy grade is determined by using the symptom
with the highest score between 1 and 10. A symptom scored
from 1 to 3 equalled a clinical grade of 1; a symptom scored
from 4 to 6 equalled a clinical grade of 2 and if it scored from 7
to 10 it equalled a clinical grade of 3. These were then categorised
into three groups. Grade of 1 illustrated a mild PN, 2 moderate
and 3 severe.
The World Health Organization Quality of Life Scale Brief
Version (WHOQOL-BREF) was used to assess QoL. The
WHOQOL-BREF consists of 26 items. Each item uses a
Likert-type ﬁve-point scale. These items are distributed in four
domains. The four domains of QoL are (a) physical health and
level of independence (seven items); (b) psychological well-
being (eight items); (c) social relationships (three items) and
(d) environment (eight items). There are also two items that
were examined separately: one which asked about the individ-
ual’s overall perception of QoL and the other which asked
about the individual’s overall perception of his or her health.
Each item uses a Likert-type ﬁve-point scale. Most scores are
scaled in a positive direction where higher scores denote
higher QoL. Domain scores were scaled in a positive
direction (higher scores denoting a higher QoL) (Hakuzimana
2005). Participants were questioned regarding their experience
relating to the above domains in the 2 weeks prior to data
collection.
Ethical clearance to conduct the study was provided by the Uni-
versity of the Western Cape. Once permission to conduct the
study was obtained from the relevant parties, the researcher and
trained research assistants visited the outpatients’ clinic and eli-
gible patients were approached and invited to participate in the
study while waiting for the doctors to attend to them. The aims
and objectives of the study were explained to each participant.
All subjects who agreed to participate provided written informed
consent. The researcher completed the SPNS and WHOQOL-
BREF questionnaires. Demographic data, including age, gender,
level of education, occupation, marital status and the length of
time participants had known their HIV status was also collected
from the participants.
Data entry and statistical analysis were performed using the SPSS
(Statistical Package for Social Science) software, version 15.0.
Descriptive statistics, such as mean and standard deviation,
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were used to examine demographic characteristics of the sample
and to summarise the score of the QoL. One-way analysis of var-
iance (ANOVA) and independent sample t-tests were performed
to determine a signiﬁcant difference between QoL domain scores
and demographic characteristics. The level of statistical signiﬁ-
cance was set at p , 0.05, while chi-square tests were used to
demonstrate the association between demographic characteristics
such as age and severity of PN.
Results
A total of 185 participants completed the two questionnaires. The
ages ranged from 19 to 73 years. The participants’ mean age was
38.7 SD + 9.6 years. Table 1 illustrates demographic character-
istics of the study sample.
A total of 75 (40.5%) out of 185 participants reported at least one
of the three symptoms of PN. The most commonly reported
symptoms were pain, aching or burning, while the least
common reported symptoms were pins and needles in feet and
legs. The mean subjective PN score was 1.69, with a standard devi-
ation of +0.88. In addition, out of 75 participants who reported
symptoms at the time of data collection, 44 (58.7%) were in grade
1 whereas 10 (13.3%) were in grade 2 and 21 (28%) in grade
3. Chi-square tests were used to demonstrate association
between age and clinical severity grade. There was a signiﬁcant
association (p ¼ 0.001 , 0.005).
Table 2 presents the demographic information and mean scores
of QoL domains and their respective mean differences. Multiple
comparisons of means were performed using Tukey’s test. The
results from Student’s t-test and ANOVA showed that a signiﬁ-
cant difference existed with respect to the ages of the partici-
pants in the psychological domain (p ¼ 0.028). Lower scores
were seen among subjects who were older than 60 years com-
pared to those who were less than 30 years old. However,
there was no signiﬁcant difference in QoL in the physical,
social and environmental domains among the different age
groups.
In addition, the comparison of the mean raw scores of QoL in
men and women showed that there was a difference in the
social relationships domains (p ¼ 0.033), with lower scores for
women in this domain. In the present study, there was no signiﬁ-
cant difference between QoL and occupation.
ANOVA was also performed to determine if there was a signiﬁ-
cant difference between the scores of the different domains and
marital status. There were no differences between QoL domains
and marital status. In the social relationships domain, there
was, however, a statistically signiﬁcant difference (p ¼ 0.030)
for the subjects who were cohabiting when compared to those
who were widowed, with subjects who were cohabiting having
higher scores. Comparisons of mean scores of QoL revealed sig-
niﬁcant differences between the physical health (p ¼ 0.000),
psychological (p ¼ 0.000), social relationships (0.033) and
environmental domains (0.040) and level of education; lower
scores were seen among subjects who did not attend school com-
pared to those with primary, secondary and tertiary level of edu-
cation. The mean scores were lower in the physical domain for
Table 1. Demographic characteristics of the study sample (n 5 185).
Demographic variables Characteristics Frequency Percentage
Age (years) ,30 35 18.9
31–40 79 42.7
41–50 49 26.5
51–60 16 8.6
.60 6 3.2
Gender Female 131 70.8
Male 54 29.2
Occupation Farm workers 160 86.5
Unemployed 12 6.5
Public or private employed 10 5.4
Self-employed 3 1.6
Marital status Married 94 50.8
Widowed 53 28.6
Separated 24 13.0
Single 12 6.5
Cohabiting 2 1.1
Level of education Primary 112 60.5
Secondary 15 8.1
University 3 1.6
Not at all 55 29.3
Time elapsed since HIV diagnosis ,2 years 54 29.2
2–4 years 110 59.5
5–7 years 12 6.5
8–10 years 7 3.8
.10 years 2 1
Original Article
Journal of Social Aspects of HIV/AIDS VOL. 9 NO. 2 JUNE 201290
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 W
es
ter
n C
ap
e] 
at 
00
:19
 04
 Fe
br
ua
ry
 20
13
 
those who did not attend school. The variable relating to time
since HIV diagnosis indicated that subjects who had known
their HIV status for 2–4 years had higher mean scores in the
social relationships domain when compared to those who had
known their status for less than 2 years.
An independent sample t-test was performed to determine if sig-
niﬁcant differences existed between the QoL domains (physical,
psychological, social and environmental) of participants with
and without PN symptoms. QoL in participants with PN
showed signiﬁcantly lower scores in the physical (p ¼ 0.013)
and psychological (p ¼ 0.020) domains. Table 3 shows the
mean values of the QoL domain for the overall cohort, partici-
pants with and without PN symptoms.
Discussion
The diagnosis of PN can generally be made by a health-care pro-
vider who is experienced in the treatment of HIV disease based on
a history of the symptoms and a comprehensive physical examin-
ation which includes testing of the reﬂexes and evaluation of the
sense of vibration, touch, pressure and pain in the extremities
(Swanson, Zeller & Paice 1998). In the present study, a researcher
established the diagnosis of PN based on the subjects’ responses,
using the SPNS. Pain, paraesthesias and numbness were the three
symptoms that differentiated those with PN from those without.
With the use of the SPNS, the overall prevalence of PN in the par-
ticipants was found to be 40.5%. The high prevalence of
Table 2. Relationship between QoL scores and demographic characteristics (n 5 185).
Demographic characteristics
Mean QoL scores
Physical health Psychological health Social relationships Environment
Age (years)
,30 13.06 15.17∗ 13.60 12.51
31–40 13.04 14.90 13.58 12.57
41–50 12.31 14.92 13.49 12.59
51–60 12.44 14.00 12.00 12.44
.60 10.83 12.83∗ 12.50 13.17
Gender
Male 12.59 14.74 13.91∗ 12.52
Female 12.78 14.84 13.18∗ 12.60
Occupation
Public or private employed 12.90 15.10 14.00 12.70
Self-employed 13.00 15.00 15.00 13.33
Unemployed 12.17 14.42 13.92 11.58
Farming or livestock 12.75 14.82 13.28 12.63
Marital status
Married 12.57 14.81 13.46 12.50
Single 13.25 14.58 13.08 12.08
Separated 12.46 14.21 12.29 12.54
Cohabiting 12.50 16.00 14.00∗ 12.00
Widowed 13.00 15.09 13.81∗ 12.85
Education
Not at all 11.60∗ 13.87∗ 12.71∗ 12.09∗
Primary 12.93∗ 15.13∗ 13.62∗ 12.82∗
Secondary 13.21 15.60 14.07 12.40
University 14.00 16.00 14.00 13.00
Time elapsed since HIV diagnosis (years)
,2 12.70 14.48 12.78∗ 12.26
2–4 12.69 14.96 13.78∗ 12.67
5–7 13.58 15.50 13.67 13.08
8–10 12.29 114.14 12.43 12.57
.10 11.50 13.50 10.00 12.50
∗p , 0.05.
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neuropathy among patients surveyed in the current study is con-
sistent with previous ﬁndings (Mbuya, Kwasa, Amayo, Kioy &
Bhatt 1996; Nicholas, Mauceri, Slate Ciampa, Corless,
Raymond, Barry, et al. 2007; Shurie & Deribew 2010; Skopelitis,
Kikotis, Kontos, Panayiotakopoulos, Konstantinou, Kordossis,
et al. 2006; Smyth, Affandi, McArthur, Bowtell-Harris, Mijch,
Watson, et al. 2007). The ﬁgures from other studies that were
found to conﬂict with the ﬁndings of this study could be due to
differences in the minimum criteria for making a diagnosis,
sample size and exclusion criteria. In the studies conducted in
Kenya (Mbuya et al. 1996) and the UK (Skopelitis et al. 2006),
objective measures were used to diagnose PN compared to the
subjective measure used in the current study.
PLWH and experiencing PN may present with a number of
different symptoms. Participants in this study mainly experi-
enced pain, aching or burning followed by numbness, while
the least reported symptoms were pins and needles. These ﬁnd-
ings are similar to those from previous studies (McArthur 1998;
Nicholas, Kemppainen, Holzemer, Nokes, Eller & Corless, et al.
2002; Wadley, Cherry, Price & Kamerman 2011). However, a
contradictory result was found in a previous study conducted
by Konchalar and Wangphonpattanasiri (2007) where numb-
ness was the dominant symptom in all patterns of HIV-related
neuropathy. Harrison and McArthur (1995) have suggested
that pain and paraesthesias could be early symptoms of the
disease, whereas numbness becomes evident as the disease
progresses.
Severity of PN in PLWH can range from mild discomfort to a
debilitating condition, making it difﬁcult for the individual to
walk or even to stand (Herramann, DeMarcaida & Akowah
2001; Schiﬁtto, McDermott, McArthur, Marder, Sacktor,
Epstein, et al. 2002). In addition, many people with early or
mild PN do not experience any symptoms, with the worst symp-
toms generally occurring in people with more advanced immuno-
suppression (Simpson & Cikurel 2006). In the present study, the
majority of PLWH with PN were in grade 1 compared to grades 2
and 3. This indicated that PN was mild in the majority of PLWH
and attending outpatients’ clinic at Rutongo Hospital who partici-
pated in the study.
Quality of life
Living with HIV/AIDS remains a severe strain for those who are
afﬂicted, for various reasons. These include the physical and
psychological effects of HIV-related symptoms, toxicity of
HAART, the difﬁculty of having to adhere to a rigid medication
regimen, the implications of the HIV infection for the patient’s
relationships and sex life, stigmatisation and the fear of dying
from the illness (Pierret 2000). As a result, the physical, psycho-
logical, social relationship and environmental domains of QoL
of PLWH are affected.
Physical health domain
The physical health domain assesses the impact of the disease on
the activities of daily living, dependence on medical substances, a
lack of energy and initiative, restricted mobility and the capacity
to work (Skevington 2002). In the present study, the mean score
for the physical domain fell in the intermediate level (12.72). As
noted in the literature, research has shown that nearly one-third
of PLWH reported problems with mobility, limitation of usual
activity and pain or discomfort (Hughes, Jelsma, Maclean,
Darder & Tinise 2004). These problems might also have contrib-
uted to the large number of subjects who rated lower scores in the
physical domain of WHOQOL-BREF in the present study. The
physical health domain of QoL deteriorates with HIV pro-
gression; in addition, the side effects of HAART may cause as
much physical discomfort as the symptoms of the illness, which
includes PN, nausea, vomiting, anaemia, headaches, skin rashes,
neutropenia, diarrhoea and abdominal discomfort (Liu, Ostrow,
Detels, Hu, Johnson, Kingsley, et al. 2006; Maenza & Flexner
1998).
Furthermore, a factor found to have a signiﬁcant effect on the
physical health domain was the level of education. In the
present study, lower scores were seen among subjects who did
not attend school compared to those with primary education.
These results support the ﬁndings of a study by Dos Santos,
Junior and Lopes (2007), where lower scores were seen among
subjects who did not attend school or only completed middle
school education compared to those with higher education. The
results of the present study observed no signiﬁcant difference
between QoL domains and different occupations of the respon-
dents. This could have been caused by the homogeneity of the
sample regarding occupation, since 86.5% of the participants
were farm workers. Skilled workers and business persons reported
better physical health domain scores when compared to others
(Wig, Lekshmi, Pal, Ahuja, Mittal & Agarwal 2006).
Psychological domain
The psychological domain assesses the patient’s own thoughts
about body image and appearance, negative feelings, positive feel-
ings, self-esteem and personal beliefs (Skevington 2002). In the
current study, the participants’ QoL scores in the psychological
domain were close to the high level (between 15 and 20). This
positive result could be due to the fact that the management of
HIV/AIDS in Rwanda includes the provision of psychological
support. In the study conducted by Uwimana and Struthers
(2007), 50% of the participants reported having received psycho-
logical support. This support could assist the individuals in
Table 3. Mean values of QoL domain for overall
cohort, participants with and without PN
symptoms (n 5 185).
QoL domain
Overall
cohort
mean
values
PLWHs
with PN
symptom
mean
values
PLWHs
without PN
symptom
mean
values
p-
Value
Physical 12.72 13.1∗ 12.2∗ 0.013
Psychological 14.81 15.1∗ 14.4∗ 0.020
Social 13.39 13.5 13.2
Environmental 12.57 12.75 12.35
∗p , 0.05.
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accepting their illness. When people start accepting their disease,
they take control over their lives and exercise self-determination
and autonomy (Murphy & Melby 1999). This approach could
result in high self-esteem and positive feelings about themselves.
Social domain
The social domain assesses the individual’s personal relationships,
social support and sexual activity (Skevington 2002). In the
present study, the mean score of the participants in the social
relationships domain of QoL fell into the intermediate level
(13.39). The fact that the participants reported that they were
experiencing challenges in this area could be as a result of their
communities’ attitudes towards them. PLWH are still being stig-
matised by the communities in which they live (Herek, Capitano
&Widaman 2002). In this study, females scored statistically lower
in the social domain than men. This result is in agreement with a
previous study where women with HIV/AIDS had lower QoL
scores as opposed to men despite having less-advanced disease;
they were also found to be likely to face a chronic disabling con-
dition that is progressive (Hader, Smith, Moore & Holmberg
2001; Nirmal, Divya, Dorairaj & Venkateswaran 2008). Moreover,
women often face more severe discrimination than men if they are
known to be HIV positive, and they are more likely to sacriﬁce
their own health for the welfare of their family and postpone
treatment. Disclosing their HIV status could lead to physical
abuse by their partners and a loss of economic stability if their
partners were to leave them.
Environmental domain
The environmental domain assesses how QoL is inﬂuenced by
factors such as ﬁnancial resources, the work environment, acces-
sibility to health and social care, freedom, security and opportu-
nities for participation in leisure activities. The mean score of
the participants in the environmental domain of QoL fell into
the intermediate level (12.57). This domain had the lowest
mean score in the present study. This ﬁnding could have resulted
from a number of factors, including the geographical setting of the
study, the ﬁnancial status of the participants and a lack of family
support. The study was conducted in a rural area where the con-
dition of the roads hampers access to health facilities. Although
the study sample included only those who attended ARV clinic,
patients could ﬁnd it difﬁcult to access the clinic due to the con-
dition of the roads. The ﬁnancial situation of the participants
could also have resulted in the low score reported for this
domain. The majority (86.5%) of the participants were farm
workers who often do not receive large salaries. Uwimana and
Struthers (2007) also reported that ﬁnancial support was one of
the greatest needs identiﬁed by PLWH in Rwanda. Family
support and occupation signiﬁcantly affect the environmental
domain of QoL in PLWH (Wig et al. 2006). The family is
usually the most important component of the immediate environ-
ment of the patient (Wig et al. 2006). The family could provide
ﬁnancial support and a sense of safety and security, resulting in
a good and supportive home environment which can help a
patient feel better. Although this is the case, there is extreme
poverty in Rwanda and it is therefore questionable whether the
families who might need support themselves would be able to
provide support to the family members who are suffering from
HIV/AIDS.
Limitations of the study
There were a number of limitations to this study. No medical
investigations or assessment tools for identifying PN were used.
The presence of PN was therefore based on self-report, which
could have been exaggerated. In the present study, the critical
indicators of disease progression, such as CD4 count and viral
load, as well as data on antiretroviral tuberculosis (TB) medi-
cation were not assessed. Thus, an association between the pro-
gression of the disease and the presence and severity of PN
could not be determined. The study population was biased in
that it only included those who were actively seeking routine
medical care. Those who did not schedule or keep regular clinic
visits were not included; consequently, the results of this study
cannot be generalised to all HIV patients in the Rulindo district.
With regard to the environmental domain of QoL, it is impossible
to know how much of the environmental problems experienced
were due to the condition of the participants or due to living in
an impoverished area. A comparison of the results with the
(WHOQOL-BREF) scores for the general population would
therefore have been very useful.
Conclusion
The results provided in this article indicate a high prevalence of
neuropathy among PLWH and attending an outpatients’ clinic
at Rutongo Hospital in the Rulindo district of Rwanda. In
addition, patients with neuropathy had lower QoL scores in the
physical and psychological domains than those without neuropa-
thy symptoms. The management of PLWH should therefore
include interventions to optimise QoL and screening for neuropa-
thy symptoms so that sufferers can liaise with their medical pro-
viders to ﬁnd medical and supportive therapies that could assist
them.
For further research, an investigation into CD4, viral load, antire-
troviral and TB medication history would be advantageous for a
more in-depth analysis of PN in PLWH. In the present study,
the researcher established the diagnosis of PN based on the sub-
jects’ responses using the SPNS. In future research, objective con-
ﬁrmation of PN, such as nerve conduction studies and grading of
severity, may beneﬁt patient management.
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